U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
BCD-089
Preferred Name English
LEVILIMAB
INN  
Official Name English
levilimab [INN]
Common Name English
Levilimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN MONOCLONAL BCD-089 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BCD-089 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
SMS_ID
300000005903
Created by admin on Wed Apr 02 01:21:03 GMT 2025 , Edited by admin on Wed Apr 02 01:21:03 GMT 2025
PRIMARY
FDA UNII
P7UV3L2H80
Created by admin on Wed Apr 02 01:21:03 GMT 2025 , Edited by admin on Wed Apr 02 01:21:03 GMT 2025
PRIMARY
CAS
2035008-70-7
Created by admin on Wed Apr 02 01:21:03 GMT 2025 , Edited by admin on Wed Apr 02 01:21:03 GMT 2025
PRIMARY
NCI_THESAURUS
C173804
Created by admin on Wed Apr 02 01:21:03 GMT 2025 , Edited by admin on Wed Apr 02 01:21:03 GMT 2025
PRIMARY
INN
10905
Created by admin on Wed Apr 02 01:21:03 GMT 2025 , Edited by admin on Wed Apr 02 01:21:03 GMT 2025
PRIMARY
ACTIVE MOIETY
LEVILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966